Parkinson’s biomarker discovery boosted by new proteomic dataset in the PPMI
Parkinson’s disease presents across many distinct patient subtypes and involves numerous pathways, presenting a vast collection of proteins and processes relevant to the condition that need to be quantified, analysed and investigated. Recently, The Michael J.